Can I be reimbursed for Venetoclax/Venetoclax? What is the price after medical insurance?

Venetoclax/Venetoclax (Venetoclax) The original drug has been launched in China and has been included in the medical insurance. It is a Class B drug in the medical insurance, so it can be reimbursed, but only qualified patients can be reimbursed. Patients who do not meet the conditions may need to purchase the drug at their own expense. Regarding the price after medical insurance, the price of Venekra will vary according to different specifications and regions. Patients can calculate the actual cost to be paid based on the local medical insurance reimbursement ratio.

Venclexta is a drug used to treat adults with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or acute myeloid leukemia (AML). The brand names are Venclexta and Venclyxto. Veneclaattaches to a protein called Bcl-2, which is high in CLL cancer cells, helping the cancer cells survive longer in the body and making them resistant to anti-cancer drugs. By attaching to Bcl-2 and blocking its action, venetoclax causes cancer cells to die, thereby slowing the progression of the disease. The most common side effects are low neutrophil levels, diarrhea, nausea, anemia, nose and throat infections, and fatigue.

The price of the original drug Venekra sold domestically, specifications 100mg*14 tablets per box, may be around 2,000 RMB, while the Turkish version of the original drug sold overseas, 100mg*112 tablets per box, is priced at more than 10,000 RMB (the price may fluctuate due to exchange rates). There are also cheaper generic drugs of Venacla sold overseas. Their pharmaceutical ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, the price of 100mg*120 tablets produced by a Bangladesh pharmaceutical factory is more than 4,000 yuan per box (the price may fluctuate due to the exchange rate).